深圳为合成生物产业立法！这波操作有多“硬核”？

Core Viewpoint - The article discusses the recent legislative measures taken by Shenzhen to promote the synthetic biology industry, which is considered a new "golden track" in the context of the third biotechnology revolution. The new regulations aim to support innovation and development in this emerging sector, establishing a comprehensive service support system for synthetic biology enterprises [2][3]. Summary by Sections Legislative Framework - Shenzhen has passed the "Regulations on Promoting the Innovative Development of the Synthetic Biology Industry," which will take effect on October 1. This legislation is a pioneering effort in the field of industrial promotion and aims to address development bottlenecks in the synthetic biology sector [2][3]. Industry Support and Ecosystem - The regulations outline a full-chain service support system for synthetic biology, emphasizing the importance of source innovation for technology transfer. Approximately 40% of new synthetic biology enterprises in China have been established in Shenzhen over the past three years [4]. Product Market Entry - The regulations include measures to shorten the product market entry cycle for synthetic biology products, addressing the challenges of lengthy approval processes. This includes exploring new models for evaluation and technical institutions, as well as promoting the market demand for synthetic biology products through curated lists and procurement facilitation [6][7]. Financial and Spatial Support - The regulations reinforce the need for spatial and financial support for the synthetic biology industry. They prioritize land supply for enterprises and encourage financial institutions to lower financing costs for startups in this sector. Additionally, there are efforts to streamline approval processes and enhance the regulatory environment for synthetic biology enterprises [7].